Truviska Pharmaceutical Private Limited - Company Profile

It is a business services private limited company based in Ahmadabad City, Gujarat, India, established in 2025.
2025 Ahmadabad City, Gujarat, India Active
Last Updated:
Access Report
About Truviska Pharmaceutical Private Limited

Truviska Pharmaceutical Private Limited, a active private limited company, was established on 17 July 2025 in Ahmadabad City, Gujarat, India. it holds CIN: U46497GJ2025PTC165147. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹50.00 K and a paid-up capital of ₹50.00 K .

Formerly known as Truviska Pharmaceutical Private Limited. Its leadership includes Dinesh Jabalsinh Bhati (Additional Director), Subhashkumar Mehta (Director), Jyotiben Subhashkumar Mehta (Director). Past directors included Harsh Subhashbhai Mehta. It is based at B-808, Titanium Square, B/H. Sarveshwar Tower,, Ahmadabad City, Gujarat, 380054.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U46497GJ2025PTC165147

  • Registration Number

    165147

  • Incorporation Date

    17 July 2025

  • Authorized Capital

    ₹50.00 K

  • Paid-Up Capital

    ₹50.00 K

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 50.00 K
  • Paid Up Capital ₹ 50.00 K
  • Company Age 7 Months 6 Days
Company report

Truviska Pharmaceutical Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Truviska Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Truviska Pharmaceutical Private Limited?
Current Directors
Name Designation Appointment Date Status
Dinesh Jabalsinh Bhati Additional Director 01 Aug 2025 Current
Subhashkumar Mehta Director 17 Jul 2025 Current
Jyotiben Subhashkumar Mehta Director 17 Jul 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Individual Subscriber - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Truviska Pharmaceutical.
Truviska Pharmaceutical revenue growth over time
Truviska Pharmaceutical profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Truviska Pharmaceutical?

Unlock access to Truviska Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Truviska Pharmaceutical?

Unlock and access historical data on people associated with Truviska Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Truviska Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Truviska Pharmaceutical's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Truviska Pharmaceutical
Recent Activity within the Organization
  • Director Appointment

    Dinesh Jabalsinh Bhati was appointed as a Additional Director was appointed as a Additional Director on 01 Aug 2025 & has been associated with this company since 6 months 22 days . was recorded as a recent event.

  • Director Appointment

    Subhashkumar Mehta was appointed as a Director was appointed as a Director on 17 Jul 2025 & has been associated with this company since 7 months 6 days . was recorded as a recent event.

  • Director Appointment

    The activity Jyotiben Subhashkumar Mehta was appointed as a Director was appointed as a Director on 17 Jul 2025 & has been associated with this company since 7 months 6 days . was completed.

  • Company Incorporation

    The activity Truviska Pharmaceutical Private Limited was registered on 17 Jul 2025 with Roc Ahmedabad & aged 7 months 6 days as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Truviska Pharmaceutical Private Limited?

The CIN of Truviska Pharmaceutical Private Limited is U46497GJ2025PTC165147.

Where is Truviska Pharmaceutical Private Limited headquartered?

Truviska Pharmaceutical Private Limited is headquartered at B-808, Titanium Square, B/H. Sarveshwar Tower,, Ahmadabad City, Gujarat, 380054.

When was Truviska Pharmaceutical Private Limited incorporated?

Truviska Pharmaceutical Private Limited was incorporated on 17 July 2025.

Who are the current directors of Truviska Pharmaceutical Private Limited?

The current directors of Truviska Pharmaceutical Private Limited are

Is Truviska Pharmaceutical Private Limited a listed company?

Truviska Pharmaceutical Private Limited is unlisted.

What is the capital structure of Truviska Pharmaceutical Private Limited?

The authorized capital of Truviska Pharmaceutical Private Limited is ₹50.00 K , and the paid-up capital is ₹50.00 K .

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available